Nuvectis Pharma, Inc. (NVCT) Institutional Ownership & Insider Trading
83 institutions reported holding Nuvectis Pharma, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NVCTNuvectis Pharma, Inc.Follow NVCT — free
—
Price chart with a free account
- Market cap
- 653.3M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters83 institutions held 31.5% of the shares. Across filers that reported both quarters, shares held changed +128.6%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 83 | 10 | +128.6% | 33 | 27 | 11 | 5 |
| Mar 26 | 62 | 4 | +7.2% | 19 | 12 | 9 | 1 |
| Dec 25 | 48 | 4 | +14.6% | 25 | 3 | 9 | 8 |
| Sep 25 | 53 | 4 | +4.2% | 13 | 10 | 13 | 5 |
| Jun 25 | 47 | 3 | +57.7% | 15 | 21 | 6 | 8 |
| Mar 25 | 33 | 2 | +55.0% | 12 | 10 | 3 | 7 |
| Dec 24 | 31 | 1 | +10.3% | 13 | 6 | 7 | 6 |
| Sep 24 | 31 | 1 | -11.7% | 9 | 3 | 10 | 13 |
Nuvectis Pharma, Inc. — questions
- Who owns Nuvectis Pharma, Inc. stock?
- 83 institutions reported Nuvectis Pharma, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: TANG CAPITAL MANAGEMENT LLC (4.8%), BlackRock, Inc. (3.1%), PERCEPTIVE ADVISORS LLC (3.1%).
- Are Nuvectis Pharma, Inc. insiders buying or selling?
- 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Nuvectis Pharma, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.